Revolutionizing the future of medical care with a groundbreaking technological innovation: a constant temperature meticulously maintained at 18 ºC.
After nearly a decade of meticulously selecting from a vast array of raw materials and dedicating immense effort to the pioneering research and development of cutting-edge temperature control technology, Qingdao Dmd Medical Technology Co., Ltd. has proudly achieved a monumental breakthrough. The company has ingeniously developed an array of products, including constant temperature ice bags, insulin storage cups, constant temperature hot compress bags, and constant temperature eye bags. These advanced devices are capable of reliably maintaining precise temperatures ranging from an impressive -20 ° C to a remarkable -50 ° C, with some of these innovative technologies making their mark in various industries.
When children are under the weather with a fever and their temperature remains below 38.5 ºC, healthcare professionals commonly recommend physical cooling. Traditional methods involve applying a chilled towel or gently wiping the back and armpits with warm water. However, many parents encounter challenges in mastering these scientific cooling techniques effectively.
Baby skin is particularly sensitive; if exposed to temperatures below 10 ºC, there is a risk of frostbite. At 10-15 ºC, the skin may endure stinging and discomfort. However, 18 ºC is identified as the ideal temperature for physical cooling, mirrored by settings in hospital ICU brain protection equipment at this exact temperature for optimal care.
In a landmark advancement in 1987, Busto introduced the notion of mild hypothermia brain protection, which encompasses maintaining a body surface temperature between 30 ºC and 35 ºC, alongside an external cold compress device temperature of 18 ºC to 20 ºC. This area of low-temperature therapy has captivated the medical community once again, currently utilized in clinical settings to decrease intracranial pressure, reduce brain edema, safeguard damaged neurons, and mitigate complications and aftereffects of ischemic hypoxic encephalopathy.
Audited Supplier 
){kind=link}